Skip to content

A clinical trail to compare the effect of EasyV-Gel and VWASH in management of Kaphaja Yonivyapad (Vulvovaginal Candidiasis)

A Study To Evaluate the Effect of EasyV-Gel In Comparison With VWASH In Kaphaj Yonivyapad ( Vulvovaginal Candidiasis ) - In Vitro And Randomized Comparative Clinical Study - NILL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087332
Enrollment
60
Registered
2025-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N768- Other specified inflammation of vagina and vulva

Interventions

None listed

Sponsors

Dr Avni Kantharia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Patient of Kaphaj Yonivyapada (Vulvovaginal candidiasis) Married women

Exclusion criteria

Exclusion criteria: Women suffering from Diabetes, STD, Hepatitis B, HIV or with known case of any other debilitating disease. Pregnant woman. Unmarried Perimenopausal Cervical erosion Patients with IUD Cervicitis

Design outcomes

Primary

MeasureTime frame
EasyV-Gel more effective than VWASHTimepoint: BT=1st day 8th day AT=15th day Treatment duration:15 days Final Assessment: 15th day

Secondary

MeasureTime frame
EasyV-Gel equally effective than VWASHTimepoint: BT=1st day 8th day AT=15th day Treatment duration:15 days Final Assessment: 15th day

Countries

India

Contacts

Public ContactDr Avni Kantharia

Parul Institute of Ayurved and Research

abharavi22@gmail.com8281578252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026